These activities are designated for neurologists, internal medicine and primary care physicians, and other clinicians involved in the screening and treatment of patients with multiple sclerosis.
The objectives of this initiative are to provide monthly touchpoints so that clinicians have a comprehensive and up-to-date understanding of the best practices in multiple sclerosis management. This includes innovative webcasts derived from major scientific conferences synthesized for the practicing clinician, interactive practice-based cases, and articles from peer-reviewed scientific journals. This program is designed to provide timely, scientific data that can be applied directly to the clinical settings for in-the-trenches clinicians.
Learning Objective (s)
- Apply current best practices and evidence-based guidelines in the management of multiple sclerosis to provide optimal patient outcomes
CME Information: Physicians
Statement of Accreditation
Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Projects In Knowledge® designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Information: Nurses
Specific credit information can be found on each activity's web page.
CE Information: Pharmacists
Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
To obtain CME/CE credit:
- Read or listen to each activity carefully.
- Complete/submit each posttest and evaluation.
- Instantly access and print out your certificate.
There is no fee for this activity.
Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.
For more information on the contract, click here.
The Disclosure Policy of Projects In Knowledge® requires that all those who have control of the content of CE activities comply with the ACCME’s Standards for Commercial Support regarding disclosure of relevant financial relationships. Faculty, planners, PIK editorial scientific team, reviewers, and medical writers are required to disclose any financial relationship they or their spouse/partner have with any ACCME-defined commercial interest* relevant to the content of this activity. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed during the presentations.
Anne H. Cross, MD has conducted contracted research for EMD Serono, Roche, National MS Society, NIH, and The Conrad N. Hilton Foundation; and has received consulting fees from Biogen Idec, Genzyme (Sanofi-aventis), Novartis Pharmaceuticals Corporation, and Teva Neuroscience.and has ownership/interest in Affymetrix.
Peggy Peck, Editor-in-Chief has disclosed no relevant relationships.
Patricia K. Coyle, MD has received contracted research support from Actelion Pharmaceuticals, Genentech, a member of the Roche Group, NINDS, Novartis Pharmaceuticals Corporation, and Opexa Therapeutics, Inc; and has received consulting fees from Accordant Health Services (a CVS Caremark Company), Acorda Therapeutics, Bayer Healthcare Pharmaceuticals, Biogen Idec, Celgene, EMD Serono, Inc, Genentech, a member of the Roche Group, Genzyme Corporation, a Sanofi Company, Novartis Pharmaceuticals Corporation, and Teva Neuroscience.
Patricia Melville, NP has received consulting fees from Biogen, EMD Serono, Inc., Novartis Pharmaceuticals Corporation, and Sanofi-Genzyme; and has received honoraria from Biogen, EMD Serono, Inc., Novartis Pharmaceuticals Corporation, Sanofi-Genzyme, and Teva Neuroscience.
Amy Perrin Ross, MSN has received honoraria from Acorda Therapeutics, Biogen Idec, Novartis Pharmaceuticals Corporation, Pfizer Inc, Questcor Pharmaceuticals, and Teva Neuroscience; and has received consulting fees from Acorda Therapeutics, Allergen, Bayer Healthcare Pharmaceuticals, EMD Serono, Genzyme Corporation, Novartis Pharmaceuticals Corporation, Pfizer Inc, Questcor Pharmaceuticals, Sanofi Aventis, and Teva Neuroscience.
James D. Bowen, MD received financial support for research activities from Acorda Therapeutics, Alexion, Allergan, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, GlaxoSmithKline, Novartis, Opexa, Osmotica, Roche, sanofi-aventis U.S. LLC, and Xenoport; has received consulting fees from Acorda Therapeutics, Biogen, EMD Serono Inc, Genzyme, a Sanofi Company, Genentech, Novartis, and Teva Neuroscience; and has received honoraria from Acorda Therapeutics, Biogen, EMD Serono Inc, Genentech, Novartis, Pfizer Inc, and Teva Neuroscience.
John R. Rinker, MD has conducted contract research for Biogen Idec.
Peer Reviewer has disclosed no relevant relationships.
Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no relevant relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no relevant relationships to disclose.
Projects In Knowledge's staff members have no relevant relationships to disclose.
These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.
The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.
This CME/CE activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.